Clough Capital Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-52,902
| Closed | -$4.35M | – | 128 |
|
|
2022
Q1 | $4.35M | Sell |
52,902
-47,553
| -47% | -$3.91M | 0.33% | 67 |
|
|
2021
Q4 | $14.7M | Buy |
100,455
+51,100
| +104% | +$7.5M | 0.99% | 32 |
|
|
2021
Q3 | $8.73M | Sell |
49,355
-49,360
| -50% | -$8.73M | 0.53% | 55 |
|
|
2021
Q2 | $15.9M | Buy |
98,715
+83,410
| +545% | +$13.5M | 0.87% | 47 |
|
|
2021
Q1 | $2.62M | Sell |
15,305
-400
| -3% | -$68.5K | 0.12% | 81 |
|
|
2020
Q4 | $3.45M | Sell |
15,705
-52,465
| -77% | -$11.5M | 0.25% | 77 |
|
|
2020
Q3 | $11.3M | Sell |
68,170
-61,790
| -48% | -$10.3M | 0.81% | 44 |
|
|
2020
Q2 | $14.8M | Buy |
129,960
+21,660
| +20% | +$2.47M | 1.45% | 19 |
|
|
2020
Q1 | $8.33M | Buy |
+108,300
| New | +$8.33M | 0.83% | 35 |
|